Comorbid Movement and Psychiatric Disorders Movement and psychiatric disorders are frequently comorbid. When they are, movement abnormalities and psychiatric symptoms often overlap and exacerbate one another. For example, in depressed patients with Parkinson disease (PD), bradykinesia and psychomotor slowing can present similarly and tremor and motor “freezing” can be worsened by anxiety.
Treatment Implications for Comorbid Diabetes Mellitus and Depression Major depression and type 2 diabetes mellitus are common chronic illnesses within the general US population, with prevalence rates of approximately 5% to 10% and 11%, respectively.1,2 Moreover, depression and type 2 diabetes mellitus, individually, can be among the most disabling chronic disorders one can acquire, and when they occur comorbidly, they are even more detrimental. Together they exhibit a bidirectional relationship, with each disease an independent risk factor for development of the other.
Migraine and Psychiatric Comorbidity: Diagnostic and Treatment Issues Migraine is not a psychiatric disorder, although behavioral factors can critically influence the onset and course of headache episodes. Beginning in the 1950s, the conceptualization of migraine as a psychophysiological disorder by Wolff1 and others ultimately supplanted the earlier and purely psychogenic or psychopathological view of migraine based on psychoanalytic principles of psychosomatic medicine.
Psychiatric Conditions Comorbid with Myalgic Encephalomyelitis and/or Fibromyalgia This article reviews the diagnostic criteria for both myalgic encephalomyelitis (ME) (ie, chronic fatigue syndrome) and fibromyalgia (FM) and describes how to differentiate them from depressive and anxiety disorders, the psychiatric conditions with which they are most often confused.
Top Research Findings That Can Change Clinical Practice Psychiatrists and other clinical providers are under increasing pressure to stay current. With the fast growth of knowledge, the challenge to keep up with the ever-growing body of information is greater than ever. There is an emerging realization that, as clinical providers, we need help in sorting and evaluating the quality of information before we can apply it to clinical practice.
Anxiety Disorders With Comorbid Substance Abuse Anxiety disorders occur in 18% to 28% of the US general population during any 12-month period.1,2 In anxiety disorder, there is a 33% to 45% 12-month prevalence rate for a comorbid substance use disorder (SUD).
Comorbid Depression and Alcohol Dependence Patients who are seen in clinical practice commonly have multiple problems, yet efficacy data often reflect treatment of a single illness. Thus, it is useful to know how standard treatment approaches need to be modified for comorbid disorders.
